From Deseret News archives:

Cancer drug may double as an arthritis treatment

Published: Wednesday, March 1, 2006 9:50 p.m. MST
 |  E-MAIL | PRINT | FONT + - 
WASHINGTON (AP) — The nation's best-selling cancer drug has won federal approval as a treatment for rheumatoid arthritis patients for whom other, older drugs don't work, Genentech Inc. and Biogen Idec Inc. said Wednesday.

The Food and Drug Administration action comes more than eight years after the agency initially approved Rituxan to treat non-Hodgkin's lymphoma.

The two companies said Rituxan should be used by patients who haven't had success with a class of rheumatoid arthritis drugs called tumor necrosis factor, or TNF, blockers. Those drugs include Enbrel, Remicade and Humira.

Comments

You can be the first to comment on this story.

previousnext

Latest comments

Are students safe from predators?

As parents, we are all taking measures in protecting our kids in different...

They ought to beat the hell out of him, and see how he likes it.

Re: Irony | 8:11 a.m. Nov. 16, 2009 I was thinking the exact same thing....

Bennett at center of GOP storm

If RINOs like Bennett weren't in there voting with the democrats to spend...

And on and on. It comes back to the point. Still people hold on the...

Barzee to plead guilty

FINALLY! They got those dirty kidnapper off the streets and into prison where...

They could reduce non-business mail delivery to 3 days a week and not cause...

Utes exposed

This was a tough loss to take - but at least we didn't lose by 31.... at...

I hate to see anyone get the pink-slip, but that is the reality of coaching....

Relieved Cougs prep for Falcons

What everyone should have learned this weekend is that the Cougars remain...

Advertisements
Advertisement